Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ritika Dutta, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Nakauchi Y, Azizi A, Thomas D, Corces MR, Reinisch A, Sharma R, Cruz Hernandez D, Köhnke T, Karigane D, Fan A, Martinez-Krams D, Stafford M, Kaur S, Dutta R, Phan P, Ediriwickrema A, McCarthy E, Ning Y, Phillips T, Ellison CK, Guler GD, Bergamaschi A, Ku CJ, Levy S, Majeti R. The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia. Blood Cancer Discov. 2022 07 06; 3(4):346-367. PMID: 35532363; PMCID: PMC9338760.
    Citations:    Fields:    Translation:HumansCells
  2. Parikh DA, Ragavan M, Dutta R, Garnet Edwards J, Dickerson J, Maitra D, Aggarwal S, Lee FC, Patel MI. Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care Systems. JCO Oncol Pract. 2021 10; 17(10):e1450-e1459. PMID: 33826366.
    Citations: 3     Fields:    Translation:Humans
  3. Dutta R, Miao SY, Phan P, Fernandez-Pol S, Shiraz P, Ho D, Mannis GN, Zhang TY. Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report. J Med Case Rep. 2021 Mar 28; 15(1):170. PMID: 33773605.
    Citations:    Fields:    Translation:HumansCells
  4. Jeng MY, Dutta R, Tan IT, Zhang TY, Mannis GN. Improved outcomes of octogenarians and nonagenarians with acute myeloid leukemia in the era of novel therapies. Am J Hematol. 2020 11; 95(11):E305-E308. PMID: 32744731.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  5. Chae HD, Dutta R, Tiu B, Hoff FW, Accordi B, Serafin V, Youn M, Huang M, Sumarsono N, Davis KL, Lacayo NJ, Pigazzi M, Horton TM, Kornblau SM, Sakamoto KM. RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit. Oncotarget. 2020 Jun 23; 11(25):2387-2403. PMID: 32637030.
    Citations: 2     Fields:    
  6. Azizi A, Ediriwickrema A, Dutta R, Patel SA, Shomali W, Medeiros B, Iberri D, Gotlib J, Mannis G, Greenberg P, Majeti R, Zhang T. Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience. Leuk Lymphoma. 2020 11; 61(11):2700-2707. PMID: 32543932.
    Citations: 6     Fields:    Translation:Humans
  7. Zhang TY, Dutta R, Benard B, Zhao F, Yin R, Majeti R. IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia. Sci Transl Med. 2020 04 08; 12(538). PMID: 32269167.
    Citations: 16     Fields:    Translation:HumansAnimals
  8. Dutta R, Zhang TY, Köhnke T, Thomas D, Linde M, Gars E, Stafford M, Kaur S, Nakauchi Y, Yin R, Azizi A, Narla A, Majeti R. Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2. J Clin Invest. 2020 04 01; 130(4):1843-1849. PMID: 31895700; PMCID: PMC7108889.
    Citations: 14     Fields:    Translation:HumansCells
  9. Dutta R, Tiu B, Sakamoto KM. CBP/p300 acetyltransferase activity in hematologic malignancies. Mol Genet Metab. 2016 09; 119(1-2):37-43. PMID: 27380996.
    Citations: 22     Fields:    Translation:HumansCells
  10. Mitton B, Hsu K, Dutta R, Tiu BC, Cox N, McLure KG, Chae HD, Smith M, Eklund EA, Solow-Cordero DE, Sakamoto KM. Small molecule screen for inhibitors of expression from canonical CREB response element-containing promoters. Oncotarget. 2016 Feb 23; 7(8):8653-62. PMID: 26840025.
    Citations: 3     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Dutta's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (65)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.